WKN: | A3E5C4 |
ISIN: | DE000A3E5C40 |
Land: | Deutschland |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die 4SC-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 31. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2023 | 1,28 | 8,85 | 591,41% |
2 | 2017 | 10,42 | 21,30 | 104,34% |
3 | 2012 | 25,26 | 41,55 | 64,48% |
4 | 2010 | 61,12 | 71,41 | 16,83% |
5 | 2009 | 57,66 | 61,12 | 6,01% |
6 | 2007 | 71,88 | 68,25 | -5,05% |
7 | 2015 | 17,70 | 16,49 | -6,83% |
8 | 2019 | 11,66 | 10,75 | -7,83% |
9 | 2008 | 68,25 | 57,66 | -15,52% |
10 | 2006 | 88,08 | 71,88 | -18,39% |
11 | 2013 | 41,55 | 33,26 | -19,95% |
12 | 2020 | 10,75 | 7,85 | -26,98% |
13 | 2016 | 16,49 | 10,42 | -36,79% |
14 | 2018 | 21,30 | 11,66 | -45,24% |
15 | 2014 | 33,26 | 17,70 | -46,78% |
16 | 2024 | 8,85 | 4,30 | -51,41% |
17 | 2021 | 7,85 | 3,51 | -55,29% |
18 | 2022 | 3,51 | 1,28 | -63,53% |
19 | 2011 | 71,41 | 25,26 | -64,62% |
20 | 2025 | 4,30 | 0,51 | -88,09% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2025 | 4,30 | 0,51 | -88,09% |
2 | 2011 | 71,41 | 25,26 | -64,62% |
3 | 2022 | 3,51 | 1,28 | -63,53% |
4 | 2021 | 7,85 | 3,51 | -55,29% |
5 | 2024 | 8,85 | 4,30 | -51,41% |
6 | 2014 | 33,26 | 17,70 | -46,78% |
7 | 2018 | 21,30 | 11,66 | -45,24% |
8 | 2016 | 16,49 | 10,42 | -36,79% |
9 | 2020 | 10,75 | 7,85 | -26,98% |
10 | 2013 | 41,55 | 33,26 | -19,95% |
11 | 2006 | 88,08 | 71,88 | -18,39% |
12 | 2008 | 68,25 | 57,66 | -15,52% |
13 | 2019 | 11,66 | 10,75 | -7,83% |
14 | 2015 | 17,70 | 16,49 | -6,83% |
15 | 2007 | 71,88 | 68,25 | -5,05% |
16 | 2009 | 57,66 | 61,12 | 6,01% |
17 | 2010 | 61,12 | 71,41 | 16,83% |
18 | 2012 | 25,26 | 41,55 | 64,48% |
19 | 2017 | 10,42 | 21,30 | 104,34% |
20 | 2023 | 1,28 | 8,85 | 591,41% |